Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/iju.70042 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Purpose: This study aims to conduct a comparative analysis of Trifecta and Pentafecta outcomes between T1a and T1b renal tumors in patients undergoing robotic partial nephrectomy (RAPN). We explore the influence of clinical factors, including the RENAL nephrometry score components, on these outcomes.
Methods: A retrospective single centre study was conducted on 133 patients who underwent RAPN for T1a (n = 51) and T1b (n = 82) renal tumors between 2017 and 2023.
Percutaneous microwave ablation of cT1b renal cell carcinoma: safety and oncologic efficacy in a large, single-center elderly and comorbid cohort.
Abdom Radiol (NY)
February 2025
Department of Urology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, Madison, WI, 53792, USA.
Purpose: To evaluate safety and oncologic efficacy of percutaneous microwave ablation (MWA) for treating clinically localized T1b (cT1b) renal cell carcinoma (RCC).
Methods: This single-center retrospective study was performed under a waiver of informed consent. Seventy-four consecutive patients (49M/25F) with 76 cT1b RCC (median tumor diameter 4.
Retroperitoneal laparoscopic partial nephrectomy for multiple T1b renal carcinomas in a solitary kidney: A case report.
Urol Case Rep
January 2025
Department of Urology, the Affiliated Hospital of Qingdao University, Qingdao, 266550, China.
This case highlights the effective use of retroperitoneal laparoscopic partial nephrectomy (RLPN) in a 73-year-old female with two large renal carcinomas in her solitary kidney, including a 7 cm deeply infiltrating mass. The RLPN procedure successfully resected both tumors with a thermal ischemia time of 28 minutes, 110 minutes of surgery, and only 30 mL of blood loss. The patient's postoperative recovery was excellent, with no hemorrhage or urine leakage and only a mild increase in serum creatinine levels.
View Article and Find Full Text PDFRisk Factors for Residual Unablated Tumour Following CT-Guided Percutaneous Renal Cryoablation: Lessons from the EuRECA Registry.
Cardiovasc Intervent Radiol
February 2025
Department of Radiology, Southampton University Hospitals, Southampton, UK.
Objective: To assess tumour factors that reduce primary technical efficacy (PTE) from CT-guided renal cryoablation.
Methods: Patients were taken from the EuRECA registry between December 2014 and November 2020. To focus on tumour factors rather than individual technique, this study was limited to cases using CT and excluded procedures using cone beam, US, MRI, or laparoscopy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!